« Back
Home /
valemetostat

valemetostat

Item no.	V27912-50mg
Manufacturer	InvivoChem LLC
CASRN	1809336-39-7
Amount	50mg
Category	Reagents & Chemicals Molecules
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Description	InvivoChem Cat #:V27912CAS #:1809336-39-7Purity >=98% Description: Valemetostat, formerly known as DS-3201 or DS-3201b, is an investigational EZH1/2 dual inhibitor with anticancer activity, it targetsepigenetic regulation by inhibiting the EZH1, as well as EZH2 enzymes, which regulate gene expression by acting through histone methylation. Valemetostat is being evaluated in Phase I clinical development for severaltypes of NHLs, including ATL, peripheral T-cell lymphoma (PTCL) andB-cell lymphomas. Patients are currently being enrolled for the trial inthe US and Japan. References: https://www.clinicaltrialsarena.com/news/daiichi-sankyo-valemetostat-atl/

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50mg

available

Delivery expected until 6/5/2025

Express Delivery: Save 20 days

Compare

Add to wishlist

Recommend by mail